Established in 1991, Lipid Analytical Laboratories Inc. has been located on the first floor of the University of Guelph Research Park Centre ever since. It is fully equipped with advanced technologies and chromatographic systems for conducting research and analytical services on various lipids and fatty acid components in any biological materials.
There is significant movement in both academic and commercial operations towards the development of foods lower in cholesterol, trans-fatty acids and saturates but, higher in omega-3 fatty acids (recently established as an essential nutrient in the diet). The agrifood industries are focusing on the production of more nutritious designer foods, nutraceuticals, and specialized health products with modified fatty acid profiles.
We provide analytical and research services on many lipid compositional parameters in human or animal feeding trials, and clinical research trials for medical centres and universities. Various industries and food companies are satisfied repeat customers based on our quality service in this very specialized area of lipids and fatty acid analyses.
As part of the Laboratory Accreditation Program, the Standards Council of Canada (SCC) has granted Lipid Analytical Laboratories Inc. accreditation to ISO/IEC 17025:2017. (LAP). The accreditation process allows laboratories to demonstrate proof of their technical competence and ability to meet a performance benchmark.
Lipid Analytical Laboratories’ (Lipid Analytical) scope of accreditation for fatty acid testing is the most comprehensive in the industry. (Accredited Laboratory No. 838)
Our Management Team:
Andrew completed his BSc. (Honours) at the University of Guelph in Biological Sciences in December 2012 with specialties the fields of biochemistry, biophysics, and molecular biology.
Andrew continued his studies at the University of Guelph completing his MSc. in Biochemistry in April 2015 under the supervision of Dr. George Harauz, studying the biochemical nature of Multiple Sclerosis (MS).
Andrew worked to published on the structural characterization of a recombinant form of Mylein Basic Protein (MBP) by fluorescence resonance energy transfer (FRET) in order to determine its conformational behaviour in response to post-translational modifications and explain how these modifications may disrupt its ability to bind to and stabilize the myelin membrane thus contributing to MS pathology.
Andrew has previous experience in GLP/GMP, ISO/IEC, and USP/EP environment and has been previously designated as a subject matter expert in the field of HPLC / GLC.
Dr. Bruce Holub is University Professor Emeritus, Dept. of Human Health and Nutritional Sciences, at the University of Guelph and Senior Scientific Advisor to Lipid Analytical Laboratories Inc. within the University of Guelph Research Park Centre.
He received his Ph. D. degree from the University of Toronto (Biochemistry and Nutrition) followed by post-doctoral research as an MRC Fellow at the University of Michigan Medical School.
He has served as President, Nutrition Society of Canada, and has authored over 200 papers in medical and nutrition journals along with over 400 invited lectures in 20 different countries. Dr. Holub’s research program has been devoted to the health benefits of EPA/DHA omega-3 fatty acids from fish/fish and algal oils (for updates see his web site at www.dhaomega3.org) including the prevention and management of cardiovascular disease and the importance of DHA omega-3 from breast milk in supporting optimal infant health.
Dr. Beaumier has over 34 years of experience in the field of analytical chemistry. As a past president of the Canadian Society for Chemistry (2008-2009) and one of the founders of Maxxam Analytics, Canada‟s largest private analytical testing laboratory, Dr. Beaumier has been at the forefront of innovations in the areas of the development of testing methods, improving analytical accuracy, and quality systems and standards. These efforts have spanned a large number of commercial sectors including environmental testing, genetics, pharmaceuticals, food safety, human drug testing, occupational health and safety applications, and testing services for the oil and gas industry.
Throughout his career, Dr. Beaumier has contributed significantly not only to the science of analysis but also to the ongoing development of scientific standards and public education as president of the Association of the Chemical Profession of Ontario (ACPO), the Canadian Society for Chemistry (CSC), and served on the board of Hospitals In-Common, a not for profit organization.